Author: KCCure

Kidney Cancer news from ASCO-GU

The 2018 Genitourinary (GU) Cancers Symposium is a three-day scientific and educational meeting focusing on research and clinical applications in GU cancers (which includes kidney, prostate and bladder). For the second year in a row, KCCure participated in this important kidney cancer conference.  But 2018 was a special year of “firsts” for our organization: Presenting the patient view to doctors ...

March is Kidney Cancer Awareness Month – Share your Story

For some cancers, “awareness” campaigns can save lives.  Signs and symptoms or early diagnostic tests can mean catching a cancer earlier – in a more treatable form.  But in kidney cancer, signs and symptoms usually don’t occur until a cancer is more advanced and unfortunately, we still don’t have early screening technology for kidney cancer. At KCCure, Kidney Cancer Awareness month is about bringi...

KCCure Launches National Kidney Cancer Patient Advisory Board

WASHINGTON – The Kidney Cancer Research Alliance (KCCure) announced today the formation of a national kidney cancer Patient Advisory Board; a non-voting body made up of patients, caregivers and leaders in the cancer community.  The board will be led by patient advocates Michael B. Lawing and Debra Gottsleben.  Members will provide guidance to KCCure’s research agenda, assist in developing patient ...

KCCure President Dena Battle Elected to National Cancer Institute’s Renal Task Force

WASHINGTON - Kidney Cancer Research Alliance (KCCure) President Dena Battle has been elected to the National Cancer Institute’s Renal Task Force to serve as one of two patient advocates on the panel. 

In Memory of Keith Puls

Keith M Puls (1958-2017) was diagnosed May 2017 with stage IV RCC. Keith and I began this journey scared and anxious.  We fought hard and this disease was very powerful and overwhelming.  Keith was an amazing chef, artist, and musician. My children and I were lucky to have him in our lives.  While we had plans to marry in early 2018, Keith lost his battle too soon.  We miss you and love you always...

KCRP funding – Be ready to apply!

Register today to learn more about how to apply for new kidney cancer funding! Kidney cancer research funding will be provided for the fiscal year 2017 (FY17) through a new, $10 million, stand-alone program in the Department of Defense Congressionally Directed Medical Research Programs. This program is possible thanks to the advocacy efforts of kidney cancer patients and survivors, their loved one...

KCCure Research Priorities

Research Priorities in RCC When considering the state of the science in kidney cancer research, identify up to 3 knowledge gaps that, if filled, would have significant impact on patient care.[1] Earlier detection/prevention of kidney cancer. [2] Understanding genetic drivers in RCC to identify those in need of early screening; Better tools/less invasive measures that can be used for screening; Bet...

KCCure interviews Dr. Mike Atkins about the TIVO-3 trial

KCCure talks with Dr. Michael Atkins, Deputy Director of the Georgetown-Lombardi Comprehensive Cancer Center in Washington, DC about the TIVO-3 trial and what it means for kidney cancer patients.

New Clinical Trial for Kidney Cancer Treatment

A new class of drugs called HIF-2 inhibitors could change the landscape for kidney cancer.

To Cure Kidney Cancer, Grow the Community of Specialists

Curing and treating kidney cancer is a two-part challenge: raising research funds and attracting researchers to use them.

My Kidney Cancer Team and the Road to NED

By Mike Venable - I have a medical dream team, fine doctors who are the reason I’m classed as no evidence of disease (NED).

SPORE Grant Awarded to UTSW Kidney Cancer Program

Dr. James Brugarolas discusses the $11 million award for kidney cancer research.

Lost Password


Subscribe for updates!